Baminercept
Product Specifications
UNSPSC Description
Baminercept (BG 9924) is a lymphotoxin β receptor IgG fusion protein (LTβR-Ig). Baminercept can be used for the research of many autoimmune diseases including primary Sjögren's syndrome (SS) and rheumatoid arthritis (RA) [1][2].
Target Antigen
TNF Receptor
Type
Inhibitory Antibodies
Related Pathways
Apoptosis
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/baminercept.html
Purity
99.9
Solubility
10 mM in DMSO
Smiles
[Baminercept]
References & Citations
[1]E William St Clair, et al. Clinical Efficacy and Safety of Baminercept, a Lymphotoxin β Receptor Fusion Protein, in Primary Sjögren's Syndrome: Results From a Phase II Randomized, Double-Blind, Placebo-Controlled Trial. Arthritis Rheumatol. 2018 Sep;70(9):1470-1480.|[2]Jadwiga Bienkowska, et al. Lymphotoxin-LIGHT pathway regulates the interferon signature in rheumatoid arthritis. PLoS One. 2014 Nov 18;9(11):e112545.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-P99459/Baminercept-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-P99459/Baminercept-SDS-MedChemExpress.pdf
Clinical Information
Phase 2
CAS Number
909110-25-4
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6400464-01 0.1 mL
EMP2 (Epithelial Membrane Protein 2, EMP-2, Protein XMP, XMP, MGC9056) (HRP)
Ask
View Details 
MBS6400464-02 5x 0.1 mL
EMP2 (Epithelial Membrane Protein 2, EMP-2, Protein XMP, XMP, MGC9056) (HRP)
Ask
View Details